Target intelligence / Profile preview

Ocular surface epithelial cell membrane

Molecular classification
Cellular structure, Lipid bilayer, Plasma membrane
01

Overview

The ocular surface epithelial cell membrane is a complex lipid bilayer that serves as the primary physical and biological barrier between the eye and the external environment [1]. Composed of phospholipids, cholesterol, and sphingolipids, this bilayer maintains cellular integrity and regulates the transport of solutes and water, which is critical for corneal transparency and visual acuity [2]. In conditions such as Dry Eye Disease (DED) or chemical injury, the lipid bilayer is compromised by hyperosmotic stress and inflammation, leading to increased permeability and cell death [3]. While not a traditional pharmacological target like a receptor or enzyme, it is the functional target for barrier-stabilizing agents, including lipid-based artificial tears and perfluorohexyloctane, which aim to supplement the tear film lipid layer and protect the underlying cell membranes [4]. Additionally, the bilayer is a site of unintended toxicity for ophthalmic preservatives like benzalkonium chloride, which can disrupt the membrane and exacerbate ocular surface disease [5]. Therapeutic strategies often focus on reinforcing this bilayer to prevent the cycle of inflammation and desiccation seen in chronic ocular surface disorders [4]. The integrity of this membrane is often assessed clinically through staining techniques that identify areas of barrier breach [3].

Other names
Ocular surface cell lipid bilayerCorneal epithelial cell membraneConjunctival epithelial cell membraneEpithelial plasma membrane
02

Mechanism of action

Stabilization of the cellular barrier and reduction of evaporation through the replenishment of surface lipids and protection of the epithelial membrane integrity.

03

Biological functions

Barrier functionCellular integrityOsmotic regulationProtection from pathogens
04

Disease associations

Dry eye diseaseKeratitisCorneal erosionMeibomian gland dysfunction
05

Safety considerations

Preservative-induced epithelial toxicityTransient visual blurring from lipid emulsionsEpithelial desquamationLocalized ocular irritation
06

Interacting drugs

Perfluorohexyloctane

4 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Corneal fluorescein staining (CFS)Tear osmolarityOcular Surface Disease Index (OSDI)

Beyond the preview

Go deeper on Ocular surface epithelial cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface epithelial cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call